Loading

JSM Chemistry

Molecular Docking Analysis - An aid for Selection of Promising Natural Plant Products against Diphtheria Toxin

Research Article | Open Access

  • 1. Department of CBRN defense, Institute of Nuclear Medicine and Allied Sciences, India
+ Show More - Show Less
Corresponding Authors
Rakesh Kumar Sharma, Department of CBRN defense, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India
Abstract

Molecular docking study was performed in order to identify Natural Plant Products that shows higher binding energy with Diphtheria toxin of the pathogen Corynebacterium diphtheriae, responsible for Diphtheria, a respiratory tract infection. Thirty herbals were selected based on their ethnopharmacological activities reported against different clinical problems. Five phytoconstituents from each herbal were docked with the tertiary chemical structure of Diphtheria toxin and compared with the binding potential obtained from substrate of the toxin, i.e., Nicotinamide adenine dinucleotide. Further, the potent Natural Plant Products were screened for compliance to the Lipinski rule of five with molinspiration tool. It was found that 20 Natural Plant Products from 14 herbals have shown E-value lower than Nicotinamide adenine dinucleotide. Only 03 phytoconstituents Cyanidin (Sambucus nigra), 3-hydroxyflavanone (Oxycoccus palustris) and 6-gingerol (Zingiber officinale) have shown no violation from Lipinski’s rule of five.

Keywords


•    Corynebacterium diphtheriae
•    Diphtheria toxin
•    Natural plant products
•    Molecular docking
•    Lipinski rule of five

ABBREVIATIONS

DT: Diphtheria Toxin; WHO: World Health Organization; EF-2: Elongation Factor- 2; NAD: Nicotinamide Adenine Dinucleotide; ADPR: Adenosine Diphosphate Ribose; NPPs: Natural Plant Products; SPF: Spherical Polar Fourier; MMDB: Molecular Modeling Database; SMILES: Simplified Molecular-Input LineEntry System; PDB: Protein Data Bank

Citation

Chakotiya AS, Chawla R, Tanwar A, Sharma A, Sharma RK (2016) Molecular Docking Analysis - An aid for Selection of Promising Natural Plant Products against Diphtheria Toxin. JSM Chem 4(1): 1017

INTRODUCTION

Diphtheria, a serious malady caused by Corynebacterium diphtheriae, has been known to cause intense respiratory disease attributed towards its high transmissibility and toxin intervention(s) [1-3]. The infection is predominantly portrayed by the formation of a pseudo-membrane over tonsils and pharynx, ultimately reaching up to trachea. Subsequent inflammation of pseudo-membrane leads to dyspnoea [1]. The condition becomes more serious when the toxigenic strains produce DT that is absorbed in circulation and ultimately affect many tissues [1,4]. The main challenge in clinical management of Diphtheria is the limited prognostic as well as therapeutic interventions. However, the death rate significantly declined after the introduction of first line Diphtheria antitoxin in the early 1940’s [5]. Asian nations with temperate environment are conducive for the easy growth and dissemination of C. diphtheriae, thereby making it an endemic in such geographical regions [6]. India, a South East Asian country, is considered as the hot zone of Diphtheria infection with more than 6,000 cases (~ 83.51% morbidity) recorded as per the disease surveillance report of WHO, 2015 [7]. Also an outbreak of Diphtheria is recorded by Integrated Disease Surveillance Programme in India in 2014 [8]. However, after the implementation of Expanded Programme on Immunization (EPI) by WHO in 1984, significant decline was observed in morbidity [7]. C. diphtheriae is known to be vulnerable to the first line anti-infection agents, i.e., penicillin and erythromycin [6]. Other alternative second line chemotherapeutic modalities include amoxicillin, vancomycin, clindamycin, tetracycline, rifampin, kanamycin, gentamycin, imipenem, etc. These antibiotics are acting differently on physiological pathways and molecular mechanism of the bacteria, but none of them is targeting the DT, which is one of the major virulent factors to cause death of the host cell [9]. DT inhibits protein synthesis of eukaryotic cells by inactivating EF-2 during chain elongation process of protein synthesis. DT act catalytically by utilizing NAD for transferring ADPR moiety from NAD to EF-2, thereby inactivating EF-2 and ultimately kills susceptible cell [9]. Therefore, the agent that can prevent the action of DT at mechanistic level and ultimately inhibit the inactivation of EF-2 needs to be explored. Hence in the present study rationale based molecular docking approach is employed to identify potent NPPs that can bind more efficiently with DT. The basis of this molecular docking analysis is evaluation of minimization of binding energy that is obtained by the correct conformation of the complex analyzed by using SPF correlation. Results obtained from the present study need further validation at both in vitro and preclinical levels.

MATERIALS AND METHODS

Receptor

The three dimensional crystal structure of receptor ‘DT’ was taken from MMDB (http://www.ncbi.nlm.nih.gov).

Ligands

One hundred and fifty NPPs from 30 herbals (~5 from each) and its substrate NAD were taken as ligands. The structural data format of ligands (NPPs and NAD) was obtained from PubChem and converted into SMILES formula by using Open Babel Graphical user interface program (http://openbabel.org/ docs/dev/GUI/GUI.html) [10, 11]. The PDB file formats of all ligands were attained by online SMILES translator and structure generator (http://cactus.nci.nih.gov/translate/).

Molecular Docking: Molecular simulation was performed by using Hex 6.12 with PDB file pattern filter for both receptor and ligand. The parameters involved were shape + electro complementarity, 1 grid dimension and 180° range angle of receptor and ligand to calculate the linear relationship based binding energy of receptor-ligand complex [10, 11].

Virtual screening of leads: The lead molecules were screened for drug likeliness on the basis of “Lipinski’s Rule of Five” by using Molinspiration Cheminformatics 2016.

RESULTS AND DISCUSSION

Molecular Docking: The tertiary structure of Diphtheria toxin (with PDB and MMDB ID as 1SGK and 57365, respectively) was retrieved from MMDB database. The predominant NPPs of 30 herbals were docked with Diphtheria toxin using Hex 6.12. It was found that 20 phytoconstituents of different categories from 14 herbals have shown lower E-value as compared to NAD (-300.05 Kcal/mol) (Table 1).

The ligands were also checked for conformity to the Lipinski rule of five, and the results are summarized in (Table 2). The rule states that a molecule likely to be developed as an orally active drug candidate should show no more than one violation of the following four criteria: (i) It should not have more than five hydrogen bond donors, (ii) it should not have more than 10 hydrogen bond acceptors, (iii) it should not have molecular weight greater than 500 Da, and (iv) it should not have an octanol–water partition coefficient greater than 5. Molecular properties of all NPPs were calculated by molinspiration, and it was found that 03 phytoconstituents namely Cyanidin (Sambucus nigra), 3-hydroxyflavanone (Oxycoccus palustris) and 6-gingerol (Zingiber officinale) have a good potential for eventual development as oral agents and can be potentially active drug candidates.

DISCUSSION

The objective of this study was to identify the NPPs that can bind efficiently with DT in comparison to that of NAD, substrate of DT. Many studies are ongoing for the discovery of novel drug in order to manage diphtheria based on various therapeutic rationale therapies. Discovery of antibiotics and anti-toxin is hailed as one of the biggest achievement of science as this gave a ray of hope to win over the life threatening pathogens. The disease involving toxin mediated pathophysiology is difficult to treat, as discovery of chemotherapeutic agent targeting toxin directly is still illusive. One approach to treat such pathogenic strains could be in light of the utilization of promising herbals, with restorative NPPs is being practiced in various alternative therapies. However, this practice is not normally based on modern tools of drug development. Therefore, the goal of this study is to present a molecular docking approach to select convincing plants against DT by employing Hex 6.12, which uses SPF correlation in which only top ranked correct conformation have been identified as a complex [12]. The process involves targeting bioactivity parameter, i.e., DT as receptor in order to bind the selected phytomolecules with them and its comparison with the binding energy obtained by its substrate, NAD. Therefore, it can be assumed that NPPs of selected herbals could be selected as potent agents that can inhibit the action of DT further.

Table 1: E-value of ligands < -300.05 Kcal/mol (NAD).

S.No. Phytoconstituents Herbal Class E vale(Kcal/mol)
1 Crocin Gardenia jasminoide Carotenoid -391.27
2 Nimbin Azadiracta indica Alkaloid -407.89
3 Azadirachtin Azadiracta indica Limnoid -429.03
4 Vicenin Ocimum sanctum Flavanoid glycoside -319.75
5 Eriocitrin Mentha piperita Flavanone -359.57
6 Beta carotene Solanum lycopersicum Terpenoids -359.57
7 Betulinic acid Syzigium cumunii Terpenoids -300.89
8 Ecdysterone Achyranthes aspera Sterol -317.97
9 Furosin Emblica officinalis Tannin -475.19
10 Hesperidine Citrus limonum Flavanone -471.63
11 3- hydroxyflavone Oxycoccus palustris Flavanone -304.83
12 Cycloeucalenol Tabermontana coronaria Terpenoid -396.77
13 Lupeol acetate Tabermontana coronaria Terpenoid -450.22
14 Stigmasterol Tabermontana coronaria Sterol -433.50
15 Viminalol Tabermontana coronaria Terpene -418.19
16 6-gingerol Zingiber officinale Alkaloid -357.77
17 Beta-farnasene Zingiber officinale Terpene -303.12
18 Zingiberene Zingiber officinale Terpene -309.76
19 Spirostanol Tribulus terrestris Saponin -420.3
20 Cyanidin Sambucus nigra Flavanoid -329.92

Table 2: Molinspiration Calculation of Properties for the Lipinski Rule of Five. Three NPPs (shown in bold) are drug able moieties.

S.No. Phytoconstituents n violation n atoms milogP <5 MW <500 nOH <10 nOHNH <5 nrotb
1 Cyanidin 0 21 -0.75 287.25 6 5 1
2 3- hydroxylflavone 0 38 3.45 238.24 3 1 1
3 6-gingerol 0 21 3.22 294.39 4 2 10
4 Betulinic acid 1 33 7.04 456.71 3 2 2
5 Nimbin 1 39 3.55 540.61 9 0 8
6 Ecdysterone 1 34 1.36 480.64 7 6 5
7 Cycloeucalenol 1 31 7.62 426.73 1 1 5
8 Lupeol acetate 1 34 8.71 468.77 2 0 3
9 Stigmasterol 1 30 7.87 412.70 1 1 5
10 Viminalol 1 31 8.08 426.73 1 1 0
11 Beta-farnasene 1 15 5.84 204.36 0 0 7
12 Zingiberene 1 15 5.12 204.36 0 0 4
13 Spirostanol 1 30 6.12 204.36 3 1 0
14 Beta-carotene 2 40 9.84 536.89 0 0 10
15 Azadirachtin 2 51 1.42 720.72 16 3 10
16 Eriocitrin 3 40 -1.68 564.60 14 10 4
17 Hesperidine 3 43 -0.55 234.30 15 8 7
18 Furosin 3 46 -2.56 650.45 19 10 4
19 Vicenin 3 40 -1.62 250.96 14 10 4
20 Crocin 3 68 -2.20 976.97 24 14 20

 

CONCLUSION

Our analyses have demonstrate that Molecular docking approach offers a convincing approach for the selection of promising herbal leads on the basis of binding energy as the NPPs have shown significant interaction with the selected toxin. Thus it can be used as potent herbal lead. Further studies are warranted to validate these results.

ACKNOWLEDGEMENTS

The authors are thankful to Director, INMAS for providing the experimental facilities and ASC is grateful to University Grant Commission for providing their research fellowship.

REFERENCES

1. Robins SL. Infectious diseases in the pathologic basis of disease. Philadelphia.1974.

2. Hadfield TL, Mc Evoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis. 2000; 181: 116-120.

3. Simoes EAF, Cherian T, Chow J, Shahid-Salles SA, Laxminarayan R, John TJ, et al. Acute Respiratory Infections in Children. Acute Respiratory Infections in Children. 2006.

4. Tsinzerling AV, Sizemov AN, Miasnikova TI, Zakharov AM, Shastina GV. [Tonsils in diphtheria and the Corynebacterium diphtheriae carrier state]. Arkh Patol. 1980; 42: 75-80.

5. Hunolstein CV, Alfarone G, Scopetti F, Pataracchia M, Valee RL, Franchi F, et al. Molecular epidemiology and Characteristics of Corynebacterium diphtheriae and Corynebacterium ulcerans strains isolated in Italy during the 1990s. J Med Microbiol. 2003; 52: 181-188.

6. Tiwari, TSP. In CDC Health Information for International Travel 2012- Yellow Book. 162-164.

7. WHO vaccine-preventable diseases: monitoring system. 2015 global summary.

8. Disease Alerts/Outbreaks reported and responded to by states/uts through Integrated Disease Surveillance Programme (IDSP). 2016.

9. Drazin R, Kandel J, Collier RJ. Structure and activity of diphtheria toxin. II. Attack by trypsin at a specific site within the intact toxin molecule. J Biol Chem. 1971; 246: 1504-1510.

10. Chakotiya AS, Chawla R, Thakur P, Narula A, Sharma, R.K. In silico herbal bioprospection targeting multi- drug resistant Mycobacterium tuberculosis. Int Ayur Med J. 2014; 3: 1636-1660. 

11. Chakotiya AS, Chawla R, Thakur P, Tanwar A, Narula A, Grover SS, et al. In vitro activity of promising nutraceuticals for targeting multi-drug resistant Pseudomonas aeruginosa. Nutrition. 2016.

12. Ritchie DW, Kemp GJ. Protein docking using spherical polar Fourier correlations. Proteins. 2000; 39: 178-194

Received : 09 Mar 2016
Accepted : 31 Mar 2016
Published : 02 Apr 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X